Pfizer Inc and BioNTech SE announced today that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.
- Read more about Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/pfizer-and-biontech-receive-first-us-authorization-for-emergency-use-of-covid-19-vaccine-in-adolescents
No comments:
Post a Comment